Home › NDC Lookup › RxCUI directory › RxCUI 1734683

Ertapenem 1000 MG Injection — RxCUI 1734683

RxNorm drug concept · Semantic clinical drug
RxCUI 1734683 Semantic clinical drug · SCD ● Current RxNorm concept 20 FDA products 21 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1734683
Official nameErtapenem 1000 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asertapenem 1 GM Injection; ertapenem sodium 1 GM Injection; ertapenem (as ertapenem sodium 1.046 GM) Injection
FDA products mapped20
Package NDCs mapped21
Reported Medicaid activity (SDUD)65,406 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ertapenem Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats moderate to severe bacterial infections in the abdomen, skin, lungs, urinary tract and pelvis. Adults may also get it before elective colorectal surgery to help prevent i...
  • A nurse or other professional gives it, usually once a day in adults and teens. It goes into a vein over 30 minutes or into a muscle. Your prescriber decides how long you need it.
  • The most common are diarrhea, nausea, headache and irritation where the IV goes in. Children may also have vomiting. Most were mild to moderate.
  • Get help for trouble breathing, swelling or other signs of a severe allergy. Also report seizures, tremors or muscle jerks. Call if you get diarrhea that is severe or doesn't go aw...
📖 Read our full Ertapenem Injection guide →

🕸️ Concept Web — How Ertapenem 1000 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ertapenem 1000 MG Injection RxCUI 1734683

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ertapenem 325642
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Invanz 352721
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ertapenem Injection 1734682
    • Ertapenem Injectable Product 1162505
    • Ertapenem Injection [Invanz] 1734685
    • Invanz Injectable Product 1173448
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ertapenem 1000 MG SCDC · 1734681
  • Ertapenem Injection SCDF · 1734682
  • Ertapenem Injectable Product SCDG · 1162505

Brand-Name Concepts

  • Ertapenem 1000 MG Injection [Invanz] SBD · 1734686
  • Ertapenem 1000 MG [Invanz] SBDC · 1734684
  • Ertapenem Injection [Invanz] SBDF · 1734685
  • Invanz Injectable Product SBDG · 1173448
  • Invanz BN · 352721

📦 FDA Products & Package NDCs

20 products · 21 package NDCs
21 package NDCs map to RxCUI 1734683 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00006-3843-71 10 VIAL, SINGLE-DOSE in 1 PACKAGE (0006-3843-71) / 1 INJECT... INVANZ Merck Sharp & Dohme LLC 2001-11-21
00143-9398-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9398-10) / 1 INJECTI... ertapenem sodium Hikma Pharmaceuticals USA, Inc. 2021-08-02
00143-9429-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9429-10) / 1 INJECTI... Ertapenem Hikma Pharmaceuticals USA Inc. 2025-02-28
00409-3510-22 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3510-22) / 1 INJECTI... Ertapenem Hospira, Inc. 2020-10-19
16714-0889-10 10 VIAL, SINGLE-DOSE in 1 CARTON (16714-889-10) / 1 INJECTI... ERTAPENEM SODIUM NorthStar RxLLC 2021-07-13
25021-0199-20 10 VIAL in 1 CARTON (25021-199-20) / 1 INJECTION, POWDER, L... Ertapenem Sagent Pharmaceuticals 2025-08-15
25021-0199-66 10 VIAL in 1 CARTON (25021-199-66) / 1 INJECTION, POWDER, L... Ertapenem Sagent Pharmaceuticals 2026-01-15
42023-0221-10 10 VIAL, SINGLE-DOSE in 1 PACKAGE (42023-221-10) / 1 INJECT... ERTAPENEM ENDO USA, Inc. 2018-07-26
42023-0221-85 10 VIAL, SINGLE-DOSE in 1 PACKAGE (42023-221-85) / 1 INJECT... ERTAPENEM ENDO USA, Inc. 2018-11-01
43598-0901-58 10 VIAL, SINGLE-DOSE in 1 CARTON (43598-901-58) / 1 INJECTI... ERTAPENEM SODIUM Dr.Reddys Laboratories Inc., 2021-04-29
44567-0820-10 10 VIAL, SINGLE-DOSE in 1 CARTON (44567-820-10) / 1 INJECTI... ertapenem WG Critical Care, LLC 2020-01-07
44647-0051-10 10 VIAL in 1 CARTON (44647-051-10) / 20 mL in 1 VIAL (44647... Ertapenem Savior Lifetec Corporation 2019-03-19
51810-0504-02 10 VIAL, SINGLE-DOSE in 1 CARTON (51810-504-02) / 1 INJECTI... Ertapenem Qilu Antibiotics Pharmaceutical Co., Ltd. 2024-10-31
55150-0282-09 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-282-09) / 1 INJECTI... Ertapenem Eugia US LLC 2018-06-25
55150-0282-20 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-282-20) / 1 INJECTI... Ertapenem Eugia US LLC 2018-06-25
60505-6196-04 10 VIAL in 1 CARTON (60505-6196-4) / 20 mL in 1 VIAL (60505... Ertapenem Apotex Corp 2019-04-02
63323-0823-20 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-823-20) / 1 INJECTI... Ertapenem Fresenius Kabi USA, LLC 2019-10-10
68001-0408-31 10 VIAL in 1 CARTON (68001-408-31) / 20 mL in 1 VIAL (68001... Ertapenem BluePoint Laboratories 2019-08-29
68083-0351-10 10 VIAL, SINGLE-DOSE in 1 CARTON (68083-351-10) / 1 INJECTI... Ertapenem Gland Pharma Limited 2021-03-26
72266-0159-05 5 VIAL, SINGLE-DOSE in 1 CARTON (72266-159-05) / 1 INJECTIO... Ertapenem Fosun Pharma USA Inc 2022-12-09
72266-0159-10 10 VIAL, SINGLE-DOSE in 1 CARTON (72266-159-10) / 1 INJECTI... Ertapenem Fosun Pharma USA Inc 2021-11-01
Observed labelers: ENDO USA, Inc. (2) · Eugia US LLC (2) · Fosun Pharma USA Inc (2) · Sagent Pharmaceuticals (2) · Apotex Corp (1) · BluePoint Laboratories (1) · +11 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1335 Ertapenem injection 16 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.